SecBot SecBot
DEFA14A ·Filed May 28, 2026

SBCWW

SBC Medical Group Holdings Inc
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001493152-26-025517
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the definitive proxy statement for director nominees and any shareholder proposals. The board reduction and search for a new independent director suggest ongoing governance adjustments but no immediate trading catalyst.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
SBCWW ▲ +34.17% at T+60d
NEUTRAL call +34.17% · α vs SPY +32.44% · entry $0.2496 → $0.3349
Entry = T+0 close
May 28, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.24%
$0.2496
settled 5mo ago
T+5d
0.00%
call 0.00% · α -0.32%
$0.2496
settled 5mo ago
T+20d
+23.20%
call +23.20% · α +26.34%
$0.3075
settled 4mo ago
T+60d
+34.17%
call +34.17% · α +32.44%
$0.3349
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

SBC Medical Group Holdings filed a DEFA14A (additional definitive proxy soliciting materials) in connection with its 2026 Annual Meeting. The filing follows a recent 8-K (May 14, 2026) where independent director Mike Sayama declined re-election, reducing the board to four members. The company is searching for a fifth independent director. No financial figures or specific voting items are disclosed in the filing.

Key Facts

  • DEFA14A filed as additional definitive proxy soliciting materials for the 2026 Annual Meeting.
  • On May 14, 2026, independent director Mike Sayama notified he would not seek re-election.
  • Board reduced to four members effective prior to the 2026 AGM.
  • Board is searching for a fifth independent director to join after the AGM.
  • No financial data, earnings, or material agreements disclosed in the filing.

Financial Impact

No financial impact disclosed.

Risk Factors

  • Governance uncertainty with board reduction and pending director search.
  • Potential for dissident shareholder activity given the proxy solicitation context.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-025517
Document: 0001493152-26-025517-index-headers.html0001493152-26-025517
Document: 0001493152-26-025517-index.html0001493152-26-025517
Document: 0001493152-26-025517.txt0001493152-26-025517
3 reports for SBCWW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SBCWW — sortable, filterable
TypeNow
May 28, 2026
21w ago
DEFA14A
NEUTRAL ★ 3/10
$0.2496 $0.3349▲ +34.17%▲ +32.44%—
May 14, 2026
23w ago
8-K
BEARISH ★ 6/10
$0.2496 $0.2601▼ −4.21%▼ −0.62%—
Apr 22, 2026
26w ago
8-K
NEUTRAL ★ 4/10
$0.2496 $0.2399▼ −3.89%▼ −8.90%—
Showing 3 of 3

US Market Status

Market Open — Closes in 3h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026